Announced details
Preventive healthcare, sleep, women’s healthcare, healthcare digital transformation, femtech, and screening for cancer, cardiovascular disease, cerebrovascular disease, and musculoskeletal disease
Approximately 36,000 members (as of the end of March 2026, across HIMEDIC)
株式会社ハイメディック is a 100%-owned subsidiary of RESORTTRUST,INC. It conducts cohort research on the relationship between sleep and disease with Well-being Yokohama General Incorporated Association, Yokohama City University, and 株式会社SOXAI. 株式会社ウェルコンパス is a joint venture with DeNA Co.,Ltd. that supports healthcare digital transformation.
Well-being Yokohama General Incorporated Association (headquarters: Yokohama, Kanagawa; representative director: Kuribayashi Yukio (栗林幸夫)), Yokohama City University (headquarters: Yokohama, Kanagawa; president: Ishikawa Yoshihiro (石川義弘)), 株式会社SOXAI (head office: Yokohama, Kanagawa; president and representative director: Watanabe Tatsuhiko (渡邉達彦)), and DeNA Co.,Ltd. (head office: Shibuya-ku, Tokyo; president, representative director and CEO: Okamura Shingo (岡村信悟)). BASEGATE Yokohama Kannai Clinic is the facility where the medical screenings are conducted.
15-year membership term
7th Floor, BASEGATE Yokohama Kannai Tower, 1-1-1 Minatocho, Naka-ku, Yokohama, Kanagawa
Total membership qualification fee (admission fee): ¥3,575,000, including tax (pre-tax price: ¥3,250,000; consumption tax: ¥325,000); monthly membership fee: ¥53,900, including tax (pre-tax price: ¥49,000; consumption tax: ¥4,900)
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Grand HIMEDIC Club, HIMEDIC Yokohama Bay Course, HM Yokohama Bay Course Well-being Premium, SOXAI RING2 |
| Counterparty | Well-being Yokohama General Incorporated Association, Yokohama City University, 株式会社SOXAI, BASEGATE Yokohama Kannai Clinic, 株式会社ウェルコンパス, DeNA Co.,Ltd. |
| Counterparty overview | Well-being Yokohama General Incorporated Association (headquarters: Yokohama, Kanagawa; representative director: Kuribayashi Yukio (栗林幸夫)), Yokohama City University (headquarters: Yokohama, Kanagawa; president: Ishikawa Yoshihiro (石川義弘)), 株式会社SOXAI (head office: Yokohama, Kanagawa; president and representative director: Watanabe Tatsuhiko (渡邉達彦)), and DeNA Co.,Ltd. (head office: Shibuya-ku, Tokyo; president, representative director and CEO: Okamura Shingo (岡村信悟)). BASEGATE Yokohama Kannai Clinic is the facility where the medical screenings are conducted. |
| Relationship with the Company | 株式会社ハイメディック is a 100%-owned subsidiary of RESORTTRUST,INC. It conducts cohort research on the relationship between sleep and disease with Well-being Yokohama General Incorporated Association, Yokohama City University, and 株式会社SOXAI. 株式会社ウェルコンパス is a joint venture with DeNA Co.,Ltd. that supports healthcare digital transformation. |
| Offering price | Total membership qualification fee (admission fee): ¥3,575,000, including tax (pre-tax price: ¥3,250,000; consumption tax: ¥325,000); monthly membership fee: ¥53,900, including tax (pre-tax price: ¥49,000; consumption tax: ¥4,900) |
| Launch date | 5 June 2026 (stated as the service launch date, not as a scheduled date) |
| Applicable area | Preventive healthcare, sleep, women’s healthcare, healthcare digital transformation, femtech, and screening for cancer, cardiovascular disease, cerebrovascular disease, and musculoskeletal disease |
| Registration number and expiry date | 15-year membership term |
| Location | 7th Floor, BASEGATE Yokohama Kannai Tower, 1-1-1 Minatocho, Naka-ku, Yokohama, Kanagawa |
| Location scale | Gross floor area: 1,843 m² |
| Usage history | Approximately 36,000 members (as of the end of March 2026, across HIMEDIC) |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To contribute to extending healthy life expectancy and the development of women’s healthcare in Japan by pursuing “zero-level prevention,” which addresses causes at the pre-onset stage of disease and creates an environment conducive to better health.